Synopsis of recent research by authors named "Ron Kohavi"
* His 2020 article discusses how technology companies execute hundreds of concurrent A/B tests on millions of users, contrasting this approach with traditional, more costly randomized controlled trials (RCTs) in medicine.
* Kohavi highlights the increasing value of data-driven decision-making in technology, asserting that the marginal cost of conducting experiments is approaching zero, thereby challenging the traditional views of RCTs' efficiency in other domains.
